Professor, Medicine, University of Pittsburgh School of Medicine
Rheumatology
Dr. Thomas A. Medsger, MD
|
|
Give Review
Thomas Medsger is an expert in the field of Rheumatology. He graduated from Perelman School of Medicine at the University of Pennsylvania. He received awards:"CMS Meaningful Use Stage 1 Certification" and "Top MD". Doctor Thomas A. Medsger, MD is also published. He has 43 publications published. The lastest publication: "Derivation and external validation of a 5-year mortality prediction rule for patients with early diffuse cutaneous systemic sclerosis.' He is registered with Medicare and accepts Medicare payments.
Publications
- Derivation and external validation of a 5-year mortality prediction rule for patients with early diffuse cutaneous Systemic sclerosis.
- Progress in the evolution of Systemic sclerosis classification criteria and recommendation for additional comparative specificity studies.
- Multicriteria decision analysis methods with 1000Minds for developing Systemic sclerosis classification criteria.
- Development of pulmonary hypertension in a high-risk population with Systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Sclerod...
- Localized Scleroderma and regional inflammatory myopathy.
- Derivation and validation of a prediction rule for two year mortality in early diffuse cutaneous Systemic sclerosis.
- Survival and predictors of mortality in Systemic sclerosis associated pulmonary arterial hypertension: Outcomes from the PHAROS registry.
- The significance of palpable tendon friction rubs in early diffuse cutaneous Systemic sclerosis.
- Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with Systemic sclerosis.
- Interleukin-13-producing CD8+ T Cells mediate dermal fibrosis in patients with systemic sclerosis.
- Anti-PM-Scl antibody in patients with Systemic sclerosis.
- Commentary on myofascial release therapy in systemic lupus erythematosus and Scleroderma.
- Items for developing revised classification criteria in Systemic sclerosis: Results of a consensus exercise with the ACR/EULAR working committee for classification cri...
- Validation of potential classification criteria for Systemic sclerosis.
- Connective tissue Diseases: Predicting death in SSc: planning and cooperation are needed.
- Localized expression of tenascin in Systemic sclerosis-associated lung fibrosis and its regulation by IGF binding protein (IGFBP)-3.
- GATA-3 up-regulation in CD8+ T Cells as a biomarker of immune dysfunction in systemic sclerosis, resulting in excessive interleukin-13 production.
- Scleroderma renal crisis: a pathology perspective.
- Ultraviolet radiation intensity predicts the relative distribution of Dermatomyositis and anti-Mi-2 autoantibodies in women.
- Anti-U11/U12 RNP antibodies in Systemic sclerosis: a new serologic marker associated with pulmonary fibrosis.
- Recombinant human relaxin in the treatment of Systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.
- Effector CD8+ T Cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
- Anti-U3 RNP autoantibodies in Systemic sclerosis.
- Renal biopsy findings predicting outcome in Scleroderma renal crisis.
- Clinical subsets, skin thickness progression rate, and serum antibody levels in Systemic sclerosis patients with anti-topoisomerase I antibody.
- The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile system...
- Lung transplantation in Scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension.
- Scleroderma renal crisis: a high index of suspicion speeds diagnosis and life-saving treatment.
- Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups.
- Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in Systemic sclerosis.
- Mortality in Systemic sclerosis: an international meta-analysis of individual patient data.
- Molecular recognition patterns of serum anti-DNA topoisomerase I antibody in Systemic sclerosis.
- Successful Treatment of Dry Mouth and Dry Eye Symptoms in Sjögren's Syndrome Patients With Oral Pilocarpine: A Randomized, Placebo-Controlled, Dose-Adjust...
- High-dose versus low-dose D-penicillamine in early diffuse Systemic sclerosis trial: lessons learned.
- A novel protein highly expressed in testis is overexpressed in Systemic sclerosis fibroblasts and targeted by autoantibodies.
- Analysis of systemic sclerosis in twins reveals low concordance for Disease and high concordance for the presence of antinuclear antibodies.
- Correlation of serum anti-DNA topoisomerase I antibody levels with Disease severity and activity in systemic sclerosis.
- Natural history of systemic sclerosis and the assessment of Disease activity, severity, functional status, and psychologic well-being.
- Predictors of isolated pulmonary hypertension in patients with Systemic sclerosis and limited cutaneous involvement.
- A comparison between anti-Th/To- and anticentromere antibody-positive Systemic sclerosis patients with limited cutaneous involvement.
- Predictors and outcomes of Scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
- Endothelial dysfunction is present only in the microvasculature and microcirculation of early diffuse Systemic sclerosis patients.
Schools
University Of Pennsylvania School Of Medicine
Jackson Memorial Hospital
University Pitt
University PittU Tenn
Procedures Preformed
- Joint Drainage
- Steroid Injection
Conditions Treated
- Arthritis
- Behçet's Disease
- Bursitis
- Calcium Pyrophosphate Deposition Disease
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Top MD
Education
-
University of Tennessee -
University of Pittsburgh Medical Center -
Jackson Memorial Hospital - Jackson Health System -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
UPMC Presbyterian Shadyside
Drug Facts
| NPI NUMBER | 1144294901 | |
| NPPES Provider LastName | MEDSGER | |
| NPPES Provider FirstName | THOMAS | |
| NPPES Provider ZIPCode | 152133403 | |
| NPPES Provider State | PA | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 503.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 29.0 | |
| Percent Opioid Claims | 5.77 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1144294901 |
| Last Name Of The Provider | MEDSGER |
| First Name Of The Provider | THOMAS |
| View All |
Similar Doctors
|
|
Dr. Joanne Sickeri, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Helfrich, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary C. Wasko, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Antonio A. Achkar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robyn T. Domsic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Larry W. Moreland, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Siamak Moghadam-Kia, MD |
|
|
Dr. Christine Peoples, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phillip Balk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kelly D. Krohn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frances J. Lomibao, MD |